Leann P. Quinn

The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B

Leann P. Quinn, Barry Crook, Mark Hows et al. · British Journal of Pharmacology · 2008 · 118 citations · Full text

LABORAS™: Initial pharmacological validation of a system allowing continuous monitoring of laboratory rodent behaviour

Leann P. Quinn, Tania O. Stean, Brenda Trail et al. · Journal of Neuroscience Methods · 2003 · 85 citations

Animal Testing, Continuous Monitoring, Initial Pharmacological Validation +11

Anticonvulsant actions of LY 367385 ((+)-2-methyl-4-carboxyphenylglycine) and AIDA ((RS)-1-aminoindan-1,5-dicarboxylic acid)

Astrid G. Chapman, Ping K. Yip, Joan S Yap et al. · European Journal of Pharmacology · 1999 · 79 citations

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11

Further validation of LABORAS™ using various dopaminergic manipulations in mice including MPTP-induced nigro-striatal degeneration

Leann P. Quinn, Tania O. Stean, Helen Chapman et al. · Journal of Neuroscience Methods · 2006 · 41 citations

Neurodegenerative Diseases, Various Dopaminergic Manipulations, Mptp-induced Nigro-striatal Degeneration +9

A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: Pharmacological validation with R-(−)-deprenyl

Leann P. Quinn, M.J. Perren, Kim Brackenborough et al. · Journal of Neuroscience Methods · 2007 · 39 citations

Molecular Pharmacology, Beam-walking Apparatus, Behavioral Neuroscience +9